Epidemiology of Psychiatric Disorders in Children and Adolescent at Egypt

NCT04762394 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2021-02-21

No results posted yet for this study

Summary

Pediatric, developmental and mental health problems are more common than renal, cardiac and renal problems.

Compartmental problems were often conceptualised across two broad spectrums: internalising intrapersonal problems like anxiety, depression and withdrawal and externalising problems such as Interpersonal problems such as hyperactivity and aggression.

Mental disorders with long-term consequences can result in children and adolescents, undermining health compliance and reducing societies' ability to be safe and productive. As, children and adolescent have long-term deteriorating effects of mental health problems are often serious.

Early detection and identification of problems are in the best interest of children, adolescents, their families, and the community as a whole. All three are important.

how epidemiology can help our understanding of children and adolescent mental health: the burden of the community, measurement and tracking highly significant.

This study will display the first large-scale study of psychiatric disorders in children and adolescents in the Egypt . to provide services, including prevention and intervention based on evidence of mental health, a population-representative child survey and adolescent mental estimates disorders were needed urgently

Conditions

  • Child Behavior Disorders
  • Child Mental Disorder
  • Adolescent Behaviour Disorder

Interventions

BEHAVIORAL

The Child Behavior Checklist (CBCL),

It consists of 113 items; the parents complete it to detect emotional and behavioural problems in children and adolescents aged 6 to 18 years. It is scored on a three-point Likert scale (0=absent, 1= occurs sometimes, 2=occurs often). The time duration for item responses is the past six months.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-20
Primary Completion
2022-02-20
Completion
2023-02-20

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04762394 on ClinicalTrials.gov